Role of intravitreal bevacizumab in neovascular glaucoma.
about
Anti-vascular endothelial growth factor for control of wound healing in glaucoma surgeryAnti-vascular endothelial growth factor for neovascular glaucomaAnti-vascular endothelial growth factor for control of wound healing in glaucoma surgeryClinical use of Bevacizumab in treating refractory glaucomaRecent advances in the management of neovascular glaucoma.Clinical and histological characteristics of canine ocular gliovascular syndrome.Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab.Drug-induced uveitisIntravitreal bevacizumab (Avastin) injection for neovascular glaucoma: a survey on 23 cases throughout 12-month follow-upIntravitreal bevacizumab for the treatment of neovascular glaucoma associated with central retinal artery occlusion.Intravitreal bevacizumab in the treatment of neovascular glaucoma secondary to central retinal vein occlusion: a case reportAngiogenesis: trabeculectomy and bevacizumab.Medical and surgical treatment of neovascular glaucoma.Bevacizumab in Glaucoma: Where do We Stand?Effect of subconjunctival and intraocular bevacizumab injections on corneal neovascularization in a mouse model.Evaluation of cytotoxicity of bevacizumab on VEGF-enriched corneal endothelial cellsIntracameral bevacizumab and mitomycin C Trabeculectomy for eyes with neovascular glaucoma: a case series.Reply to 'Comment on: Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab'.Low-dose subconjunctival bevacizumab to augment trabeculectomy for glaucoma.Intravitreal bevacizumab with or without mitomycin C trabeculectomy in the treatment of neovascular glaucoma.The effect of intravitreal bevacizumab injection before Ahmed valve implantation in patients with neovascular glaucoma.Regression of rubeosis in the fellow eye after intravitreal ranibizumab injection.Adverse events associated with intraocular injections of bevacizumab in eyes with neovascular glaucoma.Anti-VEGF therapy for the treatment of glaucoma: a focus on ranibizumab and bevacizumab.
P2860
Q24186464-347A3EBB-C69B-42FF-9AAE-F92FA6A82179Q24197589-AE14ADCB-02F0-4527-AAD1-F4B7A6A1B3AEQ24200772-533CCB53-9AB9-402F-934C-6D31B535764BQ28083405-8276872A-F9A1-4FF1-AF53-9FE1B54C1476Q34734475-9A4F903B-CFE7-4C67-88FA-93A1345DF54FQ35235652-F026DDED-667A-4C5E-8633-5E882567B2E7Q35872579-A69402C8-268C-4B0B-BE24-843CFECD814EQ36797491-1B7C0813-2133-4357-805A-9AB925BDA41FQ37142444-2FC8D276-5F70-4C16-AEFA-D780E7E46ECBQ37338111-779D99F9-4B4D-43C1-8940-52A92BB0FB4CQ37437644-352DDC80-E37B-4BC9-86D0-432299E1945CQ37448483-0FFA220F-02D4-4484-88C8-3A483FE7DE93Q37883865-00F73980-FAD1-493A-9A10-05E195B127EFQ39059786-74282DE3-5222-4DCA-A4B5-3E5F7A3057E4Q39918424-17E7244D-75FC-450B-960F-ADE06E6B8F21Q40018607-0F94FA35-EE82-45D4-9E5C-89FED5062F1DQ42196444-94FA6A6F-E5F9-43D4-8553-AD5D1C3EF903Q42723668-A47DD0D9-C9A7-43C1-9FC6-DF2C78259BE9Q42789148-D362DC28-A84D-4FB1-B289-195889D9D8C1Q42789157-FDEE556E-F6F9-4D67-9324-2AB8358725DCQ44958263-8E6D9646-5D1F-460A-AF1A-3CD7EFF9D487Q44995662-A400B0BD-A0CE-4CBD-8A9D-70120A4AB7FDQ50990756-EDE400DB-0075-4D0B-82A7-C98D5A1B5C30Q53362175-FF5AD902-ECF9-4EBD-BF9C-FE2FB61127A2
P2860
Role of intravitreal bevacizumab in neovascular glaucoma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Role of intravitreal bevacizumab in neovascular glaucoma.
@en
type
label
Role of intravitreal bevacizumab in neovascular glaucoma.
@en
prefLabel
Role of intravitreal bevacizumab in neovascular glaucoma.
@en
P2093
P356
P1476
Role of intravitreal bevacizumab in neovascular glaucoma.
@en
P2093
Daniela S Monteiro de Barros
Ghada A Siam
Marlene R Moster
Moataz E Gheith
Sunir J Garg
P304
P356
10.1089/JOP.2007.0036
P577
2007-10-01T00:00:00Z